Search the Community
Showing results for tags 'dysmotility'.
Found 2 results
Anti-RNPC3 (U11/U12) antibodies in systemic sclerosis are associated with moderate to severe gastrointestinal dysmotility. After adjusting for relevant covariates and potential confounders, moderate to severe GI disease was associated with anti-RNPC3 antibodies. PubMed, Arthritis Care Res (Hoboken), 09/22/2018. (Also see Antibodies and Dysmotility) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
Spectrum of esophageal dysmotility in systemic sclerosis on high–resolution esophageal manometry as defined by Chicago classification. The severity of gastroesophageal reflux disease related endoscopic findings correlated with the degree of esophageal dysmotility on high–resolution esophageal manometry. PubMed, Dis Esophagus, 2017 Dec 1;30(12):1-6. (Also see Dysmotility Syndrome) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.